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Editorial Commentary 
Cognitive  processing  in 
migraine 
In 1995, Wray,  Mijovic-Prelec  and 
Kosslyn (1) reported that responses to 
visual tasks which primarily involved 
simple  feature  detection  were  faster 
in  migraine-with-aura  subjects  than 
in controls. In contrast,  migraine  suf- 
ferers  did  not  have  a  reaction  time 
advantage  in  tasks  that  required  a 
higher  level  of  visual  processing. 
Wray  et  al.  concluded  that  migraine 
sufferers process signals more rapidly 
than is normal  in the primary  visual 
cortex,  the  probable  origin  of  tran- 
sient  visual  disturbances  in  the 
migraine  aura.  They  suggested  that 
cortical ischemia during the migraine 
aura might selectively damage  inhib- 
itory  circuitry  in the  primary  visual 
cortex  or, alternatively, migraine  suf- 
ferers  might  inherit  an  unusually 
excitable visual cortex. 
To distinguish between these possi- 
bilities,  Palmer  and  Chronicle 
repeated Wray’s experiment  with the 
inclusion of a migraine-without-aura 
group;  however,  as  reported  in  this 
issue of Cephalalgia, they  were  unable 
to replicate Wray’s  findings either in 
migraine-with-aura  or  migraine- 
without-aura  subjects.  It  seems 
unlikely  that  methodological  differ- 
ences  between  the  two  studies 
account  for this discrepancy, because 
Palmer and Chronicle carefully repro- 
duced  Wray’s  procedures.  Perhaps 
sampling  differences  were  responsi- 
ble:  5  of  the  12  subjects  in  Wray’s 
sample had migraine  equivalents,  an 
unusually  high  representation;  9  of 
the 24 subjects in Palmer and Chron- 
icle’s  sample  were  studied  within  8 
days  of  an  attack,  whereas  Wray’s 
subjects  were  all  studied  at  least  8 
days  after  an  attack.  In  any  event, 
Palmer and Chronicle’s findings indi- 
cate that any processing advantage in 
migraine-with-aura  subjects to simple 
visual  stimuli  is  easily  hidden  by 
minor  procedural  or sampling  varia- 
tions.  Since  attentional  and  motor 
processes  have  a major  influence on 
response times, measuring  the speed 
of reactions  to  visual  stimuli is only 
an  approximate  indicator  of  visual 
processing.  More  specific  measures 
such  as  visual  evoked  potentials  (2) 
and  event-related  potentials  (3,  4) 
have  identified  abnormalities  in vis- 
ual  processing  in  migraine  sufferers, 
which,  ironically, is  more  consistent 
with Wray’s  data than with the find- 
ings presented by Palmer and Chron- 
icle. 
A  substantial  amount  of  evidence 
points  to  visual  disturbances  which 
persist subclinically in various  guises 
between attacks of migraine, and then 
intensify  during  attacks  (5).  We  still 
do  not  know  whether  these  visual 
disturbances  are  a  fundamental  part 
of  the  migraine  predisposition,  or 
whether  they  develop  secondarily 
after  repeated  episodes  of  migraine. 
Research into this issue might provide 
substantial insight into the pathogen- 
esis of migraine. For example, persist- 
ent  activation  of inherently  excitable 
subcortical  or  cortical  neuronal  cir- 
cuitry  might  eventually  recruit  a 
brainstem  disturbance  that instigates 
attacks of migraine. 
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Myogenic  cerebro- 
vascular  autoregtilation 
in migraine 
The  relevance  of new  approaches  to 
the puzzling  field of migraine patho- 
genesis  is  increasing.  At  this  time, 
transcranial  Doppler  techniques  are 
ideal for studying  “in vivo”  cerebral 
vessel reactivity in migraine patients. 
Assuming  that  vascular  phenomena 
represent part of the headache  patho- 
genesis, it is interesting to know how 
cerebral  vessels  react  to  stereotyped 
stimuli  such  as  standardized  stress 
(e.g.,  physical,  psychological,  etc.). 
The paper  of Heckmann et al., “Myo- 
genie  cerebrovascular  autoregulation 
in migraine”, demonstrates  that there 
is  a  different pattern  of  response  to 
physical stress in terms of cardiovas- 
cular  resistance  indices  between 
healthy  subjects  and  migraine  with 
and without  aura. This they attribute 
to  a myogenic  mechanism,  although 
a  similar  mechanism  could  be  pre- 
ceded  by  a brief vascular  expansion 
to  transiently  reduce  vascular  resist- 
ance.  It is likely that  the initial com- 
ponent  of  the  resistance  index 
reduction is mediated by sympathetic 
constrictor  influences,  subsequently 
sustained by metabolic and myogenic 
factors.  This  integrated  approach  to 
the  study  of cerebral  vasoregulatory 
mechanisms  should  bring  new  evi- 
dence to bear on migraine pathophys- 
iology. 
G MICIELI 
Hypnic  headaches 
In  1988,  Neil  Raskin  reported  six 
patients  between  the  ages  of 65  and 
77  with  a  previously  undescribed 
sleep-related  headache  syndrome. 
The patients awakened from sleep, at 
a  consistent  time  of  night,  with  a 
diffuse,  variably  pulsatile  headache 
lasting between 30 and 60 min. They 
all responded dramatically to lithium, 
and three of the six patients were able 
to  discontinue  the  lithium  without 
headache  recurrence.  Raskin  coined 
the  term,  “hypnic  headaches”  to 
describe  the  syndrome.  Thereafter, 
according  to  the  article  by  Morales- 
Asin  et  al.  in  this  issue,  there  were 
only two additional patients reported 
rmtill997,  a year in which there were 
reports  of  27  new  cases.  To  these, 
Morales-Asin  et al. add three of their 
own and, also in this issue, Dodick et 
al. report  19 patients  from the Mayo 
Clinic. These 22 new  cases of hypnic 
headaches  expand  the boundaries  of 
the  syndrome  to  include:  a  younger 
age  of onset  (40),  bilateral  or  unilat- 
eral pain  of pulsating  or non-pulsat- 
ing  quality,  duration  up  to  several 
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sion,  and  overlapping  features  with 
cluster  and  migraine.  Moreover,  we 
now  know  of  two  prophylactic 
agents,  other  than  lithium,  that  can be 
given  at  bedtime  to  prevent  hypnic 
headaches:  flunarizine  and  caffeine. 
RB  DAROFF 
The  second  case  of 
chronic  paroxysmal 
hemicrania-tic  syndrome 
The  possibility  of  two  such  rare  dis- 
eases  as  trigeminal  neuralgia  and 
chronic  paroxysmal  neuralgia  occur- 
ring  ipsilaterally  in the  same  patient, 
and,  furthermore,  being  diagnosed 
as  such,  seems  small.  Two  patients 
suffering  from  trigeminal  neuralgia- 
like  and  chronic  paroxysmal 
hemicrania-like  attacks  (CPH-tic 
syndrome)  have  now  been  reported. 
In the  first  case,  the  second  and  third 
trigeminal  branches  were  involved 
and  different  types  of  attack 
occurred  separately  The  new  case 
first  had  an  episode  of V2  trigeminal 
neuralgia  and  later  a period  with  Vl 
trigeminal  neuralgia-like  attacks 
combined  with  CPH-like  attacks;  the 
two  types  of  attack  were  linked  to 
each  other. 
In the first case,  carbamazepine  and 
indomethacin  had  to be administered 
to  control  both  types  of  attack.  Car- 
bamazepine  did  not  help  the  second 
patient  when  she  had  the  V2  trigem- 
inal  neuralgia,  but  both  types  of 
attack  ceased  with  indomethacin.  The 
medication  was  stopped  after  a 
month  without  recurrence. 
The  new  case  suffered  from  epi- 
sodic  paroxysmal  hemicrania-tic  syn- 
drome  rather  than  CPH-tic  syndrome. 
Because  theoretically  there  are 56 pos- 
sible variations  of this  syndrome  as to 
episodic-chronic,  concurren  t-noncon- 
current,  variations  as  to  Vl-V3- 
involvements,  and  indomethacin  sen- 
sitive-nonsensitive  cases,  it is wise  to 
stick to the term  CPH-tic  syndrome  in 
analogy  with  cluster-tic  syndrome  for 
the moment.  Even  more  variations  are 
possible  if  the  trigeminal  neuralgia- 
like  and  CPH-like  attacks  occur  con- 
tralaterally  in  future  cases.  The  ipsi- 
laterality  of  the  attacks  both  in 
cluster-tic  and  CPH-tic  attacks  in  all 
cases  so  far  reported  is of great  inter- 
est,  as  stressed  in  the  present  article. 
Future  reports  of similar  patients  may 
be  of  importance  for  the  understand- 
ing  of  the  pathophysiology  of  the 
symptoms  in  these  different  kinds  of 
attacks. 
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